Suven Pharmaceuticals’ arm gets EIR from USFDA for manufacturing facility

09 Sep 2024 Evaluate

Suven Pharmaceuticals’ Wholly Owned Subsidiary -- Casper Pharma’s formulations manufacturing facility has received the Establishment Inspection Report (EIR) from United States Food & Drug Administration (USFDA). 

The USFDA has categorized the inspection as Voluntary Action Indicated (VAI) and has deemed it as closed under 21 CFR 20.64(d)(3).

Suven Pharmaceuticals is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

Suven Pharma Share Price

1180.90 -37.40 (-3.07%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.